A Long-term Study for the Outcome of Pompe Disease
- Sponsor
- National Taiwan University Hospital
- Study ID
- NCT02399748
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
Prospectively follow patients with Pompe disease underwent enzyme replacement therapy.
Key Dates
- Start date
- Apr 30, 2007
- Status verified
- Jul 2017
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 50 participants (estimated)
Primary Outcome Measure
all cause morbidities [ Time Frame: 10 years ]
Central Contacts
- Yin-Hsiu Chien+886223123456
Related Studies
- Pompe Disease Registry ProtocolRecruiting · Genzyme, a Sanofi Company · Birmingham, Alabama
- Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe DiseaseRecruiting · Duke University · Durham, North Carolina
- Cognitive and Neurological Pathologies in Pompe DiseaseRecruiting · Duke University · Durham, North Carolina
- Avalglucosidase Alfa Pregnancy StudyRecruiting · Sanofi · Bridgewater, New Jersey